Skip to main content

Table 2 Patient persistence to index statin therapy

From: Long-term statin persistence is poor among high-risk patients with dyslipidemia: a real-world administrative claims analysis

Persistence Parameter, Mean (SD)

Elevated-TG

Cohorta

(n = 23,181)

Comparator

Cohortb

(n = 23,181)

P Value

6-month PDC

0.77 (0.26)

0.77 (0.26)

0.179

Overall PDC

0.68 (0.29)

0.68 (0.29)

0.147

Months to discontinuationc

10.4 (13.1)

10.3 (13.1)

0.599

  1. aTG ≥150 mg/dL
  2. bTG < 150 mg/dL and HDL-C > 40 mg/dL; propensity score matched to elevated-TG cohort
  3. cFor patients who discontinued
  4. Rao-Scott test was used for binary measures; robust standard errors were used for continuous measures
  5. P values calculated for comparison between the elevated-TG cohort and its propensity-matched comparator cohort
  6. HDL-C high-density lipoprotein cholesterol, PDC proportion of days covered, SD standard deviation, TG triglycerides
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X